TP53 and cancer: Altogether, p53 and its isoforms seem to mediate cell response and cell sensitivity to treatment in renal cell carcinoma; however, more research is needed to better understand the role of network interactions between p53 and its isoforms with other proteins and RNAs in this cancer.